Clinical trials
Cataract trials in Austria
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
94 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2005 | 2 |
| 2008 | 7 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 5 |
| 2013 | 6 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 6 |
| 2018 | 10 |
| 2019 | 5 |
| 2020 | 4 |
| 2021 | 6 |
| 2022 | 11 |
| 2023 | 5 |
| 2024 | 7 |
| 2025 | 4 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 45 |
| Unknown status | 34 |
| Recruiting | 6 |
| Active, not recruiting | 4 |
| Not yet recruiting | 3 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Vienna Institute for Research in Ocular Surgery | 26 |
| Medical University of Vienna | 19 |
| Prim. Prof. Dr. Oliver Findl, MBA | 18 |
| Johannes Kepler University of Linz | 8 |
| Hospital Hietzing | 3 |
| Medical University of Graz | 3 |
| Medical University Innsbruck | 2 |
| Beaver-Visitec International, Inc. | 1 |
| Croma-Pharma GmbH | 1 |
| Cutting Edge SAS | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cataract | 94 |
| Astigmatism | 7 |
| Capsule Opacification | 4 |
| Corneal Diseases | 3 |
| Glaucoma | 3 |
| Glaucoma, Open-Angle | 3 |
| Macular Edema | 3 |
| Myopia | 3 |
| Diabetes Mellitus | 2 |
| Dry Eye Syndromes | 2 |
Trials
Showing 1 to 25 of 94. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.